| 产品详情 |
| Edit |   |
|---|
| Product Name | Recombinant Human Interleukin-36 beta protein (IL36B) (Active) |
|---|
| Description | Purity > 97% as determined by SDS-PAGE and HPLC. MW: 17.7kDa. Full Length of Isoform 2: 1-157aa. tag-Free. Homo sapiens (Human). Cytokine that binds to and signals through the IL1RL2/IL-36R receptor which in turn activates NF-kappa-B and MAPK signaling pathways in target cells linked to a pro-inflammatory response. Part of the IL-36 signaling system that is thought to be present in epithelial barriers and to take part in local inflammatory response; similar to the IL-1 system with which it shares the coreceptor IL1RAP. Stimulates production of interleukin-6 and interleukin-8 in synovial fibrobasts, articular chondrocytes and mature adipocytes. Induces expression of a number of antimicrobial peptides including beta-defensins 4 and 103 as well as a number of matrix metalloproteases. Seems to be involved in skin inflammatory response by acting on keratinocytes, dendritic cells and indirectly on T cells to drive tissue infiltration, cell maturation and cell proliferation. In cultured keratinocytes induces the expression of macrophage, T cell, and neutrophil chemokines, such as CCL3, CCL4, CCL5, CCL2, CCL17, CCL22, CL20, CCL5, CCL2, CCL17, CCL22, CXCL8, CCL20 and CXCL1, and the production of proinflammatory cytokines such as TNF-alpha, IL-8 and IL-6. {ECO:0000269|PubMed:16646978, ECO:0000269|PubMed:20300079, ECO:0000269|PubMed:21242515, ECO:0000269|PubMed:21881584, ECO:0000269|PubMed:21965679, ECO:0000269|PubMed:24829417}. |
|---|
| Size | 100ug |
|---|
| Concentration | n/a |
|---|
| Applications | RUO |
|---|
| Other Names | FIL1 eta, IL-1 eta, Interleukin-1 family member 8, IL-1F8, Interleukin-1 homolog 2 |
|---|
| Gene, Accession, CAS # | IL36B,IL1F8,IL1H2, UniProt: Q9NZH7 |
|---|
| Catalog # | RPC26514 |
|---|
| Price | |
|---|
| Order / More Info | Recombinant Human Interleukin-36 beta protein (IL36B) (Active) from BIOMATIK |
|---|
| Product Specific References | n/a |
|---|
| 产品资料 |
|
|